Brainstorm Cell Therapeutics Inc. (BCLI)

Operating Cash Flow (Statement)

-$895.00K

Quarterly · Period ending: · USD

BCLI logo

BCLI Operating Cash Flow (Statement)

Latest reported-$895.00K
BCLI Quarterly Cash from Operations (-$1.59K → -$895.00K)
High-resolution chart · PNG

BCLI operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Brainstorm Cell Therapeutics Inc. Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-895,000
-1,320,000
-740,000
-1,102,000
-3,502,000
-1,631,000
-1,048,000
-3,299,000
-1,683,000
-3,063,000
-3,285,000
-6,409,000
-6,778,000
-3,986,000
-4,648,000
-4,850,000
-6,134,000
-3,688,000
-5,508,000
-6,460,000
-5,329,000
-8,968,000
-7,578,000
-6,924,000
-5,662,000
-15,029,000
-3,278,000
-3,626,000
-3,508,000
-835,000
-3,723,000
-6,594,000
55,000
-2,126,000
-2,935,000
3,843,000
-1,630,000
-1,642,000
-1,196,000
-275,000
-1,406,000
-2,981,000
-1,291,000
-2,530,000
-1,650,000
-1,937,000
-2,007,000
-1,119,000
-970,000
-391,000
-1,608,000
-713,000
-1,063,000
-670,000
-677,000
-1,074,000
-419,000
-746,000
-471,000
-897,000
-800,000
-55,000
-547,000
-400,000
-525,000
-598,000
-311,000
-213,000
-58,000
-162,000
-145,000
-446,000
-477,000
-666,000
-273,000
-949,000
-303,936
-248,064
-176,906
-383,041
-408,959
-408,959
-344,717
-311,668
-186,937
-197,648
-484,284
-5,602
-13,244
-6,970
-4,939
-3,159
-368
-1,230
334
-4,528
-1,588
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.